Science

Investigational drug stops toxic proteins tied to neurodegenerative diseases

Investigational drug stops toxic proteins tied to neurodegenerative diseases

An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein’s buildup and neurological decline associated with these disorders, suggests a pre-clinical study from researchers at Penn Medicine and Mayo Clinic. Results were published in Science Translational Medicine.

Read More…….
EurekAlert!, the online, global news service operated by AAAS, the science society,